In the 10-Q report, Taysha Gene Therapies disclosed its financial condition, stating that it has funded its operations ...

A Type D meeting was held with the FDA in March 2025 to discuss the potential regulatory path for OPGx-LCA5, including the ...

Obtained written alignment from the FDA on key elements of TSHA-102 pivotal Part B trial design and next steps on enabling ...

Hovione and Firstgene enter strategic collaboration to advance virus-like particle platform for liver cancer: Lisbon, Portugal Thursday, May 15, 2025, 13:00 Hrs [IST] Hovione, an ...

MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today announced that the U.S. Food and Drug Administration ...

Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, has announced new research ...

NewBiologix, a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through a unique DNA-based platform built on stable cell line ...

(Nasdaq: AZTA) today announced a strategic partnership between GENEWIZ from Azenta Life Sciences, a global provider of multiomics and synthetic solutions services, and Form Bio, a leading artificial ...

In an important discovery, researchers from Florida Atlantic University's Charles E. Schmidt College of Medicine have ...

BACKGROUND: Exercise improves functional outcomes in patients with diabetic cardiomyopathy (DiaCM). The molecular mechanism underlying cardiac benefits of exercise in DiaCM remains incompletely ...

Xmoor Pharma has entered into a strategic partnership with KU Leuven to support a new cell and gene therapy hub.

Even after sewage stops flowing, infectious viruses can persist for days. Scientists make disturbing discovery about viruses ...